CRTC1
Basic information
Region (hg38): 19:18683678-18782333
Previous symbols: [ "MECT1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CRTC1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 25 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 25 | 4 | 2 |
Variants in CRTC1
This is a list of pathogenic ClinVar variants found in the CRTC1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-18742927-C-T | Likely benign (Jun 26, 2018) | |||
19-18744139-C-T | not specified | Uncertain significance (Aug 01, 2022) | ||
19-18745900-G-C | not specified | Uncertain significance (Sep 25, 2023) | ||
19-18745945-C-G | not specified | Uncertain significance (Apr 09, 2024) | ||
19-18747056-G-A | not specified | Uncertain significance (Feb 03, 2022) | ||
19-18747094-C-T | Likely benign (Jun 22, 2018) | |||
19-18747096-C-T | not specified | Uncertain significance (Jan 26, 2022) | ||
19-18749822-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
19-18753490-A-G | Benign (Feb 08, 2018) | |||
19-18753562-A-G | not specified | Uncertain significance (Jul 06, 2021) | ||
19-18760017-G-A | Likely benign (Mar 29, 2018) | |||
19-18760054-G-A | not specified | Uncertain significance (Dec 04, 2024) | ||
19-18760124-C-T | not specified | Uncertain significance (Sep 08, 2024) | ||
19-18760188-G-A | Benign (Mar 29, 2018) | |||
19-18760222-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
19-18765436-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
19-18765466-A-G | not specified | Uncertain significance (Nov 13, 2023) | ||
19-18765494-C-T | not specified | Uncertain significance (May 05, 2023) | ||
19-18768599-G-A | not specified | Uncertain significance (Jun 23, 2023) | ||
19-18768645-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
19-18768650-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
19-18768654-C-T | not specified | Uncertain significance (Sep 27, 2021) | ||
19-18768744-C-A | not specified | Uncertain significance (Jul 25, 2023) | ||
19-18768750-C-A | not specified | Uncertain significance (Sep 14, 2023) | ||
19-18768750-C-T | not specified | Uncertain significance (Jun 17, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CRTC1 | protein_coding | protein_coding | ENST00000338797 | 15 | 98518 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.531 | 0.469 | 125663 | 0 | 25 | 125688 | 0.0000995 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.33 | 274 | 406 | 0.675 | 0.0000260 | 4150 |
Missense in Polyphen | 79 | 150.01 | 0.52664 | 1567 | ||
Synonymous | -0.534 | 205 | 196 | 1.05 | 0.0000149 | 1370 |
Loss of Function | 3.89 | 6 | 28.3 | 0.212 | 0.00000130 | 305 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000537 | 0.000536 |
Ashkenazi Jewish | 0.000199 | 0.000199 |
East Asian | 0.000112 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000265 | 0.0000264 |
Middle Eastern | 0.000112 | 0.000109 |
South Asian | 0.0000658 | 0.0000653 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional coactivator for CREB1 which activates transcription through both consensus and variant cAMP response element (CRE) sites. Acts as a coactivator, in the SIK/TORC signaling pathway, being active when dephosphorylated and acts independently of CREB1 'Ser-133' phosphorylation. Enhances the interaction of CREB1 with TAF4. Regulates the expression of specific CREB-activated genes such as the steroidogenic gene, StAR. Potent coactivator of PGC1alpha and inducer of mitochondrial biogenesis in muscle cells. In the hippocampus, involved in late- phase long-term potentiation (L-LTP) maintenance at the Schaffer collateral-CA1 synapses. May be required for dendritic growth of developing cortical neurons (By similarity). In concert with SIK1, regulates the light-induced entrainment of the circadian clock. In response to light stimulus, coactivates the CREB-mediated transcription of PER1 which plays an important role in the photic entrainment of the circadian clock. {ECO:0000250|UniProtKB:Q157S1, ECO:0000250|UniProtKB:Q68ED7, ECO:0000269|PubMed:23699513}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving CRTC1 is found in mucoepidermoid carcinomas, benign Warthin tumors and clear cell hidradenomas. Translocation t(11;19)(q21;p13) with MAML2. The fusion protein consists of the N-terminus of CRTC1 joined to the C-terminus of MAML2. The reciprocal fusion protein consisting of the N-terminus of MAML2 joined to the C-terminus of CRTC1 has been detected in a small number of mucoepidermoid carcinomas.;
- Pathway
- HTLV-I infection - Homo sapiens (human);Brain-Derived Neurotrophic Factor (BDNF) signaling pathway;Mesodermal Commitment Pathway;AP-1 transcription factor network
(Consensus)
Recessive Scores
- pRec
- 0.230
Intolerance Scores
- loftool
- 0.193
- rvis_EVS
- -0.4
- rvis_percentile_EVS
- 26.85
Haploinsufficiency Scores
- pHI
- 0.238
- hipred
- Y
- hipred_score
- 0.673
- ghis
- 0.643
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.917
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Crtc1
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; reproductive system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- memory;viral process;positive regulation of CREB transcription factor activity;entrainment of circadian clock by photoperiod;positive regulation of transcription by RNA polymerase II;rhythmic process;protein homotetramerization;energy homeostasis;postsynapse to nucleus signaling pathway;positive regulation of dendrite development;positive regulation of long-term synaptic potentiation;negative regulation of membrane hyperpolarization
- Cellular component
- nucleus;nucleoplasm;cytoplasm;cytosol;plasma membrane;postsynaptic density;nuclear body;dendrite;neuronal cell body;glutamatergic synapse
- Molecular function
- protein binding;cAMP response element binding protein binding